Posted inCoronavirus Updates

Rs 150 per Covaxin dose to Centre not sustainable in long run: Bharat Biotech

Hyderabad: The supply price of Bharat Biotech’s COVID-19 vaccine Covaxin to the central government at Rs 150 per dose is not sustainable in the long run, the vaccine maker said on Tuesday. The Centre’s supplying price is pushing the pricing structure for the private sector upward. Fundamental business reasons ranging from low procurement volumes, high distribution […]